Vestal Point Capital »

Maplight Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.8M 385k 17.57

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital
Jain Global

View all funds holding Maplight Therapeutics